Avid Bioservices Inc (CDMO)

[r622102675]

HALO news..."However, despite these positive financial indicators and recent developments, Piper Sandler opted to downgrade Halozyme's rating. The firm emphasized that while the recent updates are indeed beneficial, the current stock price already reflects these improvements. Moreover, Piper Sandler noted that substantial contributions from new products are not anticipated until 2025, prompting the downgrade to a Neutral rating. Following the downgrade by Piper Sandler, the market reaction was somewhat subdued, with Halozyme Therapeutics, Inc. (NASDAQ:HALO) stock price experiencing a modest increase of 0.61%. Nevertheless, the stock closed at $51.16 on June 10, reflecting ongoing investor uncertainty regarding the company's future trajectory amidst the recent rating adjustment"....Wells Fargo and Wainwright maintaining recommendations tho?...AI involved?...r